LeadIQ logo
Learn more at LeadIQ.com

Insights

Cutting-Edge Cancer Immunotherapies Enara Bio is at the forefront of developing cancer immunotherapies using Dark Antigen® and T-cell biology. The innovative EDAPT® platform enables the discovery of novel cancer-specific antigens, presenting a unique sales opportunity to healthcare institutions looking to offer advanced treatment options to cancer patients.

Recent Series B Financing Enara Bio recently secured $32.5 million in Series B financing, indicating a strong financial backing that signals growth and potential expansion. This successful funding round presents an opportunity for investors interested in supporting cutting-edge biotechnology research and development.

Strategic Collaborations With partnerships with Boehringer Ingelheim and other global pharmaceutical companies, Enara Bio is engaged in strategic collaborations to advance cancer immunotherapy research. This positions the company as an attractive partner for organizations seeking to leverage synergies and expertise in developing targeted cancer treatments.

Top Talent Recruitment Enara Bio's recent appointments of key personnel, such as the Chief Medical Officer and Vice Presidents, reflect the company's commitment to talent acquisition and leadership development. This presents a sales opportunity for professional recruitment agencies aiming to partner with a growing biotech company.

Pioneering Dark Antigen Discovery Enara Bio's focus on developing a Dark Antigen™ discovery platform opens doors for collaborations and licensing agreements in the field of cancer immunotherapies. Companies seeking novel targets for cancer treatment can explore partnership opportunities with Enara Bio to access its cutting-edge research and technology.

Similar companies to Enara Bio

Enara Bio Tech Stack

Enara Bio uses 8 technology products and services including Google Analytics, DigitalOcean Spaces, Microsoft Outlook, and more. Explore Enara Bio's tech stack below.

  • Google Analytics
    Analytics
  • DigitalOcean Spaces
    Content Delivery Network
  • Microsoft Outlook
    Email
  • Polyfill
    Javascript Libraries
  • Open Graph
    Miscellaneous
  • Microsoft
    Miscellaneous
  • PHP
    Programming Languages
  • Nginx
    Web Servers

Media & News

Enara Bio's Email Address Formats

Enara Bio uses at least 1 format(s):
Enara Bio Email FormatsExamplePercentage
First.Last@enarabio.comJohn.Doe@enarabio.com
50%
First.Last@enarabio.comJohn.Doe@enarabio.com
50%

Frequently Asked Questions

Where is Enara Bio's headquarters located?

Minus sign iconPlus sign icon
Enara Bio's main headquarters is located at Magdalen Centre, The Oxford Science Park 1 Robert Robinson Avenue Oxford, Oxfordshire OX4 4GA GB. The company has employees across 4 continents, including EuropeNorth AmericaAfrica.

What is Enara Bio's official website and social media links?

Minus sign iconPlus sign icon
Enara Bio's official website is enarabio.com and has social profiles on LinkedIn.

How much revenue does Enara Bio generate?

Minus sign iconPlus sign icon
As of September 2024, Enara Bio's annual revenue reached $15M.

What is Enara Bio's SIC code NAICS code?

Minus sign iconPlus sign icon
Enara Bio's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Enara Bio have currently?

Minus sign iconPlus sign icon
As of September 2024, Enara Bio has approximately 61 employees across 4 continents, including EuropeNorth AmericaAfrica. Key team members include Chief Scientific Officer: J. D.Chief Medical Officer: S. P.Chief Business Officer: A. F.. Explore Enara Bio's employee directory with LeadIQ.

What industry does Enara Bio belong to?

Minus sign iconPlus sign icon
Enara Bio operates in the Biotechnology Research industry.

What technology does Enara Bio use?

Minus sign iconPlus sign icon
Enara Bio's tech stack includes Google AnalyticsDigitalOcean SpacesMicrosoft OutlookPolyfillOpen GraphMicrosoftPHPNginx.

What is Enara Bio's email format?

Minus sign iconPlus sign icon
Enara Bio's email format typically follows the pattern of . Find more Enara Bio email formats with LeadIQ.

How much funding has Enara Bio raised to date?

Minus sign iconPlus sign icon
As of September 2024, Enara Bio has raised $18M in funding. The last funding round occurred on Nov 06, 2019 for $18M.
Enara Bio

Enara Bio

Biotechnology ResearchOxfordshire, United Kingdom51-200 Employees

Enara Bio is shining a light on Dark Antigen® and T-cell biology to develop cancer immunotherapies designed to improve treatment outcomes for broad populations of cancer patients. Our pioneering EDAPT® platform enables us to discover novel cancer-specific antigens from previously uncharted genomic ‘dark matter’. The result is a growing database of Dark Antigens that can address the unmet need for cancer-specific targets that are homogenously expressed and highly prevalent in solid tumors. We are advancing multiple approaches to exploit these Dark Antigen targets, with an internal focus on TCR-directed immunotherapies, and additional therapeutic partnerships with Boehringer Ingelheim and another undisclosed global pharmaceutical company. Based in Oxford, UK, Enara Bio is backed by RA Capital, Samsara Biocapital and SV Health Investors. For more information, please visit: www.enarabio.com

Comments and DMs to this account are not monitored, for any further information please head to our website

Section iconCompany Overview

Headquarters
Magdalen Centre, The Oxford Science Park 1 Robert Robinson Avenue Oxford, Oxfordshire OX4 4GA GB
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Employees
51-200

Section iconFunding & Financials

  • $18M

    Enara Bio has raised a total of $18M of funding over 2 rounds. Their latest funding round was raised on Nov 06, 2019 in the amount of $18M.

  • $10M$50M

    Enara Bio's revenue is in the range of $10M$50M

Section iconFunding & Financials

  • $18M

    Enara Bio has raised a total of $18M of funding over 2 rounds. Their latest funding round was raised on Nov 06, 2019 in the amount of $18M.

  • $10M$50M

    Enara Bio's revenue is in the range of $10M$50M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.